Podda Marta, Pagani Bagliacca Elena, Sironi Giovanna, Veneroni Laura, Silva Matteo, Angi Martina, Massimino Maura, Ferrari Andrea, Clerici Carlo Alfredo
Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Department of Surgery, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Tumori. 2020 Aug;106(4):281-285. doi: 10.1177/0300891620912022. Epub 2020 Mar 17.
To present an investigation into the intake of cannabinoids in a population of adolescents and young adults with cancer.
Sixty-six patients took part in the research: 27 reported having used cannabinoids, 21 before diagnosis; among the latter, 10 increased use during treatment.
Benefits were reported by 19% of responders regarding anxiety control, 24% for nausea, 29% for pain control and improvement of sleep, and 48% for appetite improvement.
Cannabis use by patients may often be unknown to caregivers. Studying this subject may help to better define important therapeutic aspects of these substances.
对患有癌症的青少年和青年人群中大麻素的摄入量进行一项调查。
66名患者参与了该研究：27人报告曾使用过大麻素，其中21人在诊断前使用；在后者中，10人在治疗期间增加了使用量。
19%的应答者报告在控制焦虑方面有获益，24%在缓解恶心方面有获益，29%在控制疼痛和改善睡眠方面有获益，48%在改善食欲方面有获益。
患者使用大麻的情况护理人员可能常常并不知晓。对这一主题进行研究可能有助于更好地界定这些物质重要的治疗方面。
